Drug Trial Radar · NCT02439320
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
Last checked: Nov 20, 2026Latest source record: Dec 16, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,231
Actual
Start
Apr 2015
Primary completion
Jul 2016
Study completion Aug 2016
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- CoLucid Pharmaceuticals
- First posted
- May 8, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective randomized, double-blind, placebo-controlled study in participants with disabling migraine (Migraine Disability Assessment (MIDAS) score ≥ 11).
Conditions
- Acute Migraine
Interventions
Lasmiditan 100 mgDrug
Lasmiditan 200 mgDrug
Placebo (matches lasmiditan doses)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Are Headache Pain FreeTime frame: 2 hours post dose
- Percentage of Participants Who Are Most Bothersome Symptom (MBS) FreeTime frame: 2 hours post dose
Locations
92 sites in 1 country. Site status is shown where the registry gives one.
Southview Medical Group, P.C.
Birmingham, Alabama
Simon-Williamson Clinic
Birmingham, Alabama
Achieve Clinical Research, LLC
Birmingham, Alabama
East Valley Family Physicians, PC
Chandler, Arizona
Radiant Research,Inc
Chandler, Arizona
Warner Family Practice
Chandler, Arizona
Clinical Research Advantage/Fountain Hills Family Practice
Fountain Hills, Arizona
Neurological Physicians of Arizona, Inc
Gilbert, Arizona
Thunderbird Internal Medicine
Glendale, Arizona
Lenzmeier Family Practice
Glendale, Arizona
Central Arizona Medical Associates, PC
Mesa, Arizona
Desert Clinical Research
Mesa, Arizona
Family Practice Specialists, Ltd
Phoenix, Arizona
Clinical Research Advantage Inc./Central Phoenix Medical Center LLC
Phoenix, Arizona
Thunderbird Internal Medicine
Phoenix, Arizona
Tatum Highlands Medical Associates, PLLC
Phoenix, Arizona
Radiant Research, Inc.
Scottsdale, Arizona
Fiel Family and Sports Medicine
Tempe, Arizona
Arizona Community Physicians
Tucson, Arizona
Orange Grove Family Practice
Tucson, Arizona
Cassidy Medical Group
Carlsbad, California
Allied Clinical Research
Gold River, California
Artemis Institute for Clinical Research
San Diego, California
Radiant Research, Inc.
Santa Rosa, California
Cassidy Medical Group
Vista, California
Mile High Primary Care
Aurora, Colorado
Alpine Clinical Research Center
Boulder, Colorado
Clinical Research Advantage Inc/Colorado Springs Family Practice
Colorado Springs, Colorado
Comprehensive Clinical Development- Washington DC
Washington D.C., District of Columbia
Meridien Research
Brooksville, Florida
MD Clinical
Hallandale, Florida
Suncoast Research Group
Miami, Florida
CNS Healthcare
Orlando, Florida
Radiant Research, Inc.
Pinellas Park, Florida
Infinity Clinical Research, LLC
Sunrise, Florida
Meridien Research
Tampa, Florida
Radiant Research Inc
Atlanta, Georgia
Urban Family Practice
Marietta, Georgia
Georgia Neurology and Sleep Medicine Associates
Suwanee, Georgia
Northwest Clinical Trials
Boise, Idaho
Showing 40 of 92 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.